CDH1 and benign neoplasm: Another study by Han and colleagues16 reported a sensitivity of 0.87 at a specificity of 1.0 for separating benign tumors from ovarian cancer stage I–IV, using the four proteins MUCIN-16, E-CAD, WFDC2, and IL-6.